ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Leukemia & Lymphoma Society offers translational research grants.

October 24, 2003

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984